Amylyx Pharmaceuticals Inc (AMLX)
3.98 +0.16 (+4.19%) 04/17/25 [NASDAQ]
3.90 x 300 4.10 x 100
Realtime by (Cboe BZX)
3.90 x 300 4.10 x 100
Realtime 3.98 unch (unch) 04/17/25
for Thu, Apr 17th, 2025
Results
download Want to compare other data? Select Fields| Symbol | AMLX | ZVRA | ALT | ||
| Company | Amylyx Pharmaceuticals Inc | Zevra Therapeutics Inc | Altimmune Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.83 | 6.98 | 4.41 | ||
| High | 4.12 | 7.27 | 4.62 | ||
| Low | 3.80 | 6.89 | 4.37 | ||
| Last | 3.98 | 7.15 | 4.55 | ||
| Change | +0.16 | +0.10 | +0.15 | ||
| % Change | +4.19% | +1.42% | +3.41% | ||
| Volume | 724,300 | 406,000 | 2,101,800 | ||
| 20-Day Average Volume | 810,680 | 542,450 | 2,239,100 | ||
| Previous Close | 3.82 | 7.05 | 4.40 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.66 | 7.35 | 4.80 | ||
| 20-Day Raw Stochastic | 86.14% | 44.86% | 38.24% | ||
| 20-Day Relative Strength | 56.42% | 45.15% | 41.89% | ||
| Weighted Alpha | +92.39 | +23.16 | -45.69 | ||
| Today's Opinion | 40% Buy | 88% Sell | 100% Sell | ||
| Previous Opinion | 16% Buy | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 8% Buy | Hold | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.04% since 04/10/25 | +8.99% since 04/10/25 | +9.38% since 04/10/25 | ||
| Low | 3.42 on 04/11/25 | 6.52 on 04/11/25 | 4.12 on 04/11/25 | ||
| High | 4.12 on 04/17/25 | 7.27 on 04/17/25 | 4.75 on 04/14/25 | ||
| 1-Month | |||||
| %Chg | +6.13% since 03/17/25 | -14.37% since 03/17/25 | -23.79% since 03/17/25 | ||
| Low | 3.11 on 04/09/25 | 6.19 on 04/09/25 | 3.55 on 04/08/25 | ||
| High | 4.12 on 04/17/25 | 8.40 on 03/18/25 | 6.16 on 03/24/25 | ||
| 3-Month | |||||
| %Chg | +10.56% since 01/17/25 | -11.18% since 01/17/25 | -33.67% since 01/17/25 | ||
| Low | 2.60 on 03/04/25 | 6.19 on 04/09/25 | 3.55 on 04/08/25 | ||
| High | 4.12 on 04/17/25 | 8.49 on 03/14/25 | 7.42 on 01/24/25 | ||
| 6-Month | |||||
| %Chg | +1.53% since 10/17/24 | -16.18% since 10/17/24 | -32.99% since 10/17/24 | ||
| Low | 2.60 on 03/04/25 | 6.19 on 04/09/25 | 3.55 on 04/08/25 | ||
| High | 7.27 on 11/08/24 | 9.76 on 11/25/24 | 11.16 on 11/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 352,636 | 386,929 | 350,414 | ||
| Shares Outstanding, K | 88,602 | 54,116 | 77,014 | ||
| Annual Sales | 87,370,000 | 23,610,000 | 20,000 | ||
| Annual Net Income | -301,740,000 | -105,510,000 | -95,060,000 | ||
| Last Quarter Sales | 420,000 | 12,040,000 | 10,000 | ||
| Last Quarter Net Income | -72,700,000 | -35,740,000 | -23,180,000 | ||
| 60-Month Beta | -0.53 | 1.94 | 0.91 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 03/04/25 | -0.67 on 03/11/25 | -0.33 on 02/27/25 | ||
| Latest Earnings Date | 05/08/25 | 05/14/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | 2.910 on 02/06/17 | ||
| Next Ex-Dividends Date | 03/28/18 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||